User menu

Sunitinib plus docetaxel and trastuzumab as first-line therapy for HER2+advanced breast cancer

Bibliographic reference Cardoso, F. ; Canon, J. L. ; Amadori, D. ; Dirix, L. ; Villa, E. ; et. al. Sunitinib plus docetaxel and trastuzumab as first-line therapy for HER2+advanced breast cancer.15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology (Berlin(Germany), du 20/09/2009 au 24/09/2009). In: EJC - Supplements, Vol. 7, no. 2, p. 283 (2009)
Permanent URL http://hdl.handle.net/2078.1/58667